Screener
Asset Entities ASST Medical Device — Employee compensation and benefits
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Total revenues | 2,941 | 1,511 |
| Operating expenses: | ||
| Fund management and administration | 1,489 | 1,588 |
| Employee compensation and benefits | 16,314 | 2,005 |
| General and administrative expense | 6,428 | 1,452 |
| Marketing and advertising | 79 | 102 |
| Depreciation and amortization | 86 | 54 |
| Total operating expenses | 24,396 | 5,201 |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — employee compensation and benefits?
- Asset Entities (ASST) reported medical device — employee compensation and benefits of $3.67M in Q2 2026.
- What does medical device — employee compensation and benefits mean?
- This metric aggregates all costs related to salaries, wages, bonuses, and benefits for personnel directly assigned to the business segment. It reflects the human capital investment required to drive segment-specific innovation and service delivery. Changes in this figure often correlate with headcount adjustments or shifts in the segment's labor strategy.
Ask your AI about Asset Entities's medical device — employee compensation and benefits.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude